Pictet Asset Management (UK)’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Pictet Asset Management (UK)’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$27.5M	Buy	751,098 +11,617	+2%	+$450K	0.03%	458
2021 Q1	$33.2M	Hold	739,481	–	–	0.04%	410
2020 Q4	$42.2M	Sell	739,481 -99,378	-12%	-$5.89M	0.06%	334
2020 Q3	$43M	Buy	838,859 +217,049	+35%	+$10.6M	0.07%	294
2020 Q2	$37.1M	Buy	621,810 +182,782	+42%	+$9.78M	0.06%	295
2020 Q1	$18.1M	Sell	439,028 -124,231	-22%	-$6.9M	0.04%	395
2019 Q4	$35.1M	Buy	563,259 +103,397	+22%	+$4.91M	0.06%	343
2019 Q3	$15.6M	Buy	+459,862	New	+$13.6M	0.03%	444

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Pictet Asset Management (UK)'s DCPH Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 1.6% in Q2 2021, buying an estimated $450K and bringing the position to 751,098 shares worth $27.5M. The position accounts for 0.03% of the portfolio, ranked #458.

Pictet Asset Management (UK) first reported a position in DCPH in Q3 2019 and has held it in 8 quarters since. The position peaked at $43M in Q3 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

Pictet Asset Management (UK) held 751,098 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $27.5M as of Q2 2021.
Pictet Asset Management (UK) bought 11,617 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $450K.
Deciphera Pharmaceuticals, Inc. Common Stock made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #458 holding.
Pictet Asset Management (UK) first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and has held it in 8 quarters since.
Pictet Asset Management (UK)'s Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $43M in Q3 2020.
147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.